Both in Pharmaceuticals
Viridian Therapeutics vs Bausch Health Companies
Over the past year VRDN returned +8.6% and BHC returned +19.5%; their daily moves had a correlation of 0.03.
VRDN +8.6% BHC +19.5%Growth of $1, one year, split-adjusted
| Metric | VRDN | BHC |
|---|---|---|
| Price | $25.15 | $8.14 |
| Market cap | $2.85B | $3.05B |
| Today | −0.59% | +1.50% |
| 1 month | +32.4% | +38.2% |
| 6 months | +34.1% | +44.3% |
| Year to date | −19.2% | +17.1% |
| 1 year | +6.4% | +16.0% |
| Revenue growth (YoY) | +278.7% | +9.7% |
| Gross margin | 100.0% | 75.0% |
| Net margin | −39726.8% | 14.8% |
| P/E (TTM) | — | — |
| Price / sales | 40.1× | 0.3× |
| Net cash | $625.7M | -$18.15B |
| Dividend yield | — | — |
| Volatility (60d) | 47.3% | 67.8% |
| Short % of float | 18.5% | 3.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).